Methoxyflurane

This classification denotes an anesthetic agent with the molecular formula C3H4Cl2F2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30905R8O7B, chemically known as 2,2-dichloro-1,1-difluoroethyl methyl ether but generally known as methoxyflurane, which bears US NIH Compound Identifier 4116. European Medicines Agency schedules Methoxyflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08858MIG. The term METHOXYFLURANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules methoxyflurane in its Anatomical Therapeutic Chemical (ATC) Classification. METHOXYFLURANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methoxyflurane under HS 29091990 and SITC 51616. As of Q4 2014, METHOXYFLURANE remains the US FDA Preferred Term for this commodity. Methoxyflurane bears US NLM identifiers UMLS ID C0025688 and NCI Concept Code C75098. SMILES: CLC(CL)C(F)(F)OC.